<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Interactive diabetes case 20: A 76-year-old patient with longstanding type 2 diabetes, orthostatic hypotension, and recurrent syncope – C2
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Interactive diabetes case 20: A 76-year-old patient with longstanding type 2 diabetes, orthostatic hypotension, and recurrent syncope – C2
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Interactive diabetes case 20: A 76-year-old patient with longstanding type 2 diabetes, orthostatic hypotension, and recurrent syncope – C2
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Lloyd Axelrod, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 10, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          Answer
         </span>
         <span class="headingEndMark">
          —
         </span>
         Correct.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9565" href="/z/d/drug information/9565.html" rel="external">
          Lisinopril
         </a>
         is an appropriate agent for this patient, who has systolic hypertension, diabetes, and microalbuminuria. The patient is already on this medication, and it is well tolerated without hyperkalemia, a deterioration of renal function, cough, or other complications. It is appropriate to administer this drug at bedtime, in relation to the time of day when the patient is supine, to maximize its benefits and minimize the risk of recurrent symptoms of orthostatic hypotension. Continuing the same dose but giving it at a different time minimizes the risk of harm. If this change of timing is tolerated, one can then increase the dose slowly using small increments as tolerated.
        </p>
        <p>
         In the patient under consideration, the change in time of administration of
         <a class="drug drug_general" data-topicid="9565" href="/z/d/drug information/9565.html" rel="external">
          lisinopril
         </a>
         to bedtime resulted in a small decrease in supine blood pressure readings to 177 to 187/69 to 77 mmHg with little or no change in upright blood pressure readings and no recurrence of symptoms.
        </p>
        <p>
         A goal for supine systolic blood pressure readings of 160 mmHg was chosen. This is a value that was tolerated by the patient after the cessation of
         <a class="drug drug_general" data-topicid="9105" href="/z/d/drug information/9105.html" rel="external">
          alfuzosin
         </a>
         and
         <a class="drug drug_general" data-topicid="8529" href="/z/d/drug information/8529.html" rel="external">
          hydrochlorothiazide
         </a>
         and is approximately 20 mmHg below current readings. It is higher than the office goal of 125 to 130 mmHg, which is targeted only if it can be achieved without a reduction in the diastolic pressure to &lt;55 to 60 mmHg in older adults with orthostatic hypotension (see
         <a class="medical medical_review" href="/z/d/html/3863.html" rel="external">
          "Treatment of hypertension in older adults, particularly isolated systolic hypertension"
         </a>
         ). The dose of
         <a class="drug drug_general" data-topicid="9565" href="/z/d/drug information/9565.html" rel="external">
          lisinopril
         </a>
         at bedtime was increased incrementally to 15 mg and two weeks later to 20 mg. The supine blood pressure readings fell to 156 to 168/68 to 78 mmHg with no appreciable change in upright blood pressure readings and without recurrence of symptoms.
        </p>
        <p>
         Evaluation and management of this patient is discussed further in the comment card. (See
         <a class="medical medical_answer" href="/z/d/html/4283.html" rel="external">
          "Interactive diabetes case 20: A 76-year-old patient with longstanding type 2 diabetes, orthostatic hypotension, and recurrent syncope – Comment"
         </a>
         .)
        </p>
       </div>
       <div id="topicVersionRevision">
        Topic 4281 Version 10.0
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
